Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
237 studies found for:    alps
Show Display Options
RSS Create an RSS feed from your search for:
alps
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Valproic Acid (Depakote[Registered Trademark]) to Treat Autoimmune Lymphoproliferative Syndrome (ALPS)
Conditions: ALPS;   Hypersplenism;   Lymphadenopathy
Interventions: Drug: Valproic Acid;   Procedure: CT Scan;   Procedure: Blood Sample
2 Recruiting Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Condition: Autoimmune Lymphproliferative Syndrome
Intervention:
3 Completed Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Conditions: Pregnancy;   Respiratory Distress;   Pregnancy Outcome
Intervention: Drug: Corticosteroid
4 Completed Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma
Conditions: Lymphoproliferative Disorders;   Lymphoma
Intervention:
5 Completed Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome
Conditions: Autoimmune Disease;   Lymphatic Disease;   Lymphoproliferative Disorder
Intervention: Drug: Pyrimethamine
6 Completed Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome
Conditions: Autoimmune Disease;   Lymphoproliferative Disorder
Intervention: Drug: Fansidar (pyrimethamine and sulfadoxine)
7 Not yet recruiting Robot-Assisted Therapy and Motor Learning: An Active Learning Program for Stroke
Condition: Stroke
Interventions: Device: Robot-Assisted Therapy (RT);   Device: Robot & Task-Oriented Training (RT-TOT)
8 Withdrawn Fluorodeoxyglucose Imaging Studies to Detect Lymphoma
Conditions: Autoimmune Lymphoproliferative Syndrome;   Lymphoma
Intervention:
9 Active, not recruiting Sirolimus for Autoimmune Disease of Blood Cells
Conditions: Autoimmune Pancytopenia;   Autoimmune Lymphoproliferative Syndrome (ALPS);   Evans Syndrome;   Idiopathic Thrombocytopenic Purpura;   Anemia, Hemolytic, Autoimmune;   Autoimmune Neutropenia;   Lupus Erythematosus, Systemic;   Inflammatory Bowel Disease;   Rheumatoid Arthritis
Intervention: Drug: sirolimus
10 Completed How Does Dietary Carbohydrate Influence the Formation of an Atherogenic Lipoprotein Phenotype (ALP)?
Condition: Non-alcoholic Fatty Liver Disease
Interventions: Other: High sugar low starch diet;   Other: Low sugar high starch diet
11 Unknown  Asthma Learning Project
Condition: Asthma
Interventions: Other: Educational game;   Other: Educational game + motivational interview;   Other: Motivational interview
12 Completed Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J)
Conditions: Hypertension;   Coronary Atherosclerosis
Intervention: Drug: Calcium channel blockers (amlodipine, azelnidipine)
13 Recruiting ANSiStim Study for Active Labor Pain
Conditions: Labor Pain;   Obstetric Pain
Intervention: Device: ANSiStim
14 Recruiting Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)
Condition: Prostate Cancer Metastatic
Intervention: Drug: Osteodex
15 Terminated A Phase IIb Study to Evaluate Efficacy and Tolerability of ODX (Osteodex) in Metastatic CRPC
Condition: Prostate Cancer Metastatic
Interventions: Drug: Osteodex;   Drug: Placebo
16 Completed
Has Results
Liver Function Test (LFT) Elevations in Cancer Patients and Users of Tyrosine Kinase Inhibitor (TKI) Drugs
Condition: Cancer
Intervention: Drug: Tyrosine kinase inhibitors
17 Recruiting Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis
Condition: Anemia in Chronic Kidney Disease in Non-dialysis Patients
Interventions: Drug: Roxadustat;   Drug: Placebo
18 Active, not recruiting Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Condition: Cardiac Arrest
Interventions: Drug: amiodarone;   Drug: Lidocaine;   Other: Normal saline
19 Active, not recruiting Mechanisms of Hypoglycemia Associated Autonomic Dysfunction Question 2
Condition: Type 1 Diabetes
Interventions: Drug: Alprazolam;   Drug: Placebo
20 Completed
Has Results
A Study of Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic Acid
Condition: Primary Biliary Cirrhosis
Interventions: Drug: ustekinumab 90 mg;   Drug: ustekinumab 45 mg;   Drug: ustekinumab 180 mg;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years